An integrated analysis of bile acid metabolism in humans with severe obesity.

IF 12.9 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Hepatology Pub Date : 2025-01-01 Epub Date: 2024-05-28 DOI:10.1097/HEP.0000000000000938
Ömrüm Aydin, Annika Wahlström, Patrick A de Jonge, Abraham S Meijnikman, Wilhelm Sjöland, Lisa Olsson, Marcus Henricsson, Marcus C de Goffau, Stijn Oonk, Sjoerd C Bruin, Yair I Z Acherman, Hanns-Ulrich Marschall, Victor E A Gerdes, Max Nieuwdorp, Fredrik Bäckhed, Albert K Groen
{"title":"An integrated analysis of bile acid metabolism in humans with severe obesity.","authors":"Ömrüm Aydin, Annika Wahlström, Patrick A de Jonge, Abraham S Meijnikman, Wilhelm Sjöland, Lisa Olsson, Marcus Henricsson, Marcus C de Goffau, Stijn Oonk, Sjoerd C Bruin, Yair I Z Acherman, Hanns-Ulrich Marschall, Victor E A Gerdes, Max Nieuwdorp, Fredrik Bäckhed, Albert K Groen","doi":"10.1097/HEP.0000000000000938","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Bile acids (BA) are vital regulators of metabolism. BAs are AQ6 secreted in the small intestine, reabsorbed, and transported back to the liver, where they can modulate metabolic functions. There is a paucity of data regarding the portal BA composition in humans. This study aimed to address this knowledge gap by investigating portal BA composition and the relation with peripheral and fecal BA dynamics in conjunction with the gut microbiome.</p><p><strong>Approach and results: </strong>Thirty-three individuals from the BARIA cohort were included. Portal plasma, peripheral plasma, and feces were collected. BA and C4 levels were measured employing mass spectrometry. FGF19 was measured using ELISA. Gut microbiota composition was determined through metagenomics analysis on stool samples. Considerable diversity in the portal BA composition was observed. The majority (n = 26) of individuals had a 9-fold higher portal than peripheral BA concentration. In contrast, 8 individuals showed lower portal BA concentration compared with peripheral and had higher levels of unconjugated and secondary BA in this compartment, suggesting more distal origin. The altered portal BA profile was associated with altered gut microbiota composition. In particular, taxa within Bacteroides were reduced in abundance in the feces of these individuals.</p><p><strong>Conclusions: </strong>Characterization of the portal BA composition in relation to peripheral and fecal BA increased insight into the dynamics of BA metabolism in individuals with obesity. Peripheral BA composition was much more diverse due to microbial metabolism. About 24% of the portal samples was surprisingly low in total BA; the underlying mechanism requires further exploration.</p>","PeriodicalId":177,"journal":{"name":"Hepatology","volume":" ","pages":"19-31"},"PeriodicalIF":12.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HEP.0000000000000938","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: Bile acids (BA) are vital regulators of metabolism. BAs are AQ6 secreted in the small intestine, reabsorbed, and transported back to the liver, where they can modulate metabolic functions. There is a paucity of data regarding the portal BA composition in humans. This study aimed to address this knowledge gap by investigating portal BA composition and the relation with peripheral and fecal BA dynamics in conjunction with the gut microbiome.

Approach and results: Thirty-three individuals from the BARIA cohort were included. Portal plasma, peripheral plasma, and feces were collected. BA and C4 levels were measured employing mass spectrometry. FGF19 was measured using ELISA. Gut microbiota composition was determined through metagenomics analysis on stool samples. Considerable diversity in the portal BA composition was observed. The majority (n = 26) of individuals had a 9-fold higher portal than peripheral BA concentration. In contrast, 8 individuals showed lower portal BA concentration compared with peripheral and had higher levels of unconjugated and secondary BA in this compartment, suggesting more distal origin. The altered portal BA profile was associated with altered gut microbiota composition. In particular, taxa within Bacteroides were reduced in abundance in the feces of these individuals.

Conclusions: Characterization of the portal BA composition in relation to peripheral and fecal BA increased insight into the dynamics of BA metabolism in individuals with obesity. Peripheral BA composition was much more diverse due to microbial metabolism. About 24% of the portal samples was surprisingly low in total BA; the underlying mechanism requires further exploration.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对重度肥胖症患者胆汁酸代谢的综合分析。
背景和目的:胆汁酸(BA)是新陈代谢的重要调节剂。胆汁酸在小肠中分泌 AQ6,被重吸收后运回肝脏,在肝脏中调节代谢功能。有关人体门静脉 BA 组成的数据很少。本研究旨在结合肠道微生物组,调查门静脉乙酰胆碱酯组成以及与外周和粪便乙酰胆碱酯动态的关系,从而填补这一知识空白:研究纳入了来自 BARIA 队列的 33 人。收集了门静脉血浆、外周血浆和粪便。采用质谱法测量 BA 和 C4 水平。用酶联免疫吸附法测定 FGF19。通过对粪便样本进行元基因组学分析,确定了肠道微生物群的组成。观察到门户 BA 组成具有相当大的多样性。大多数个体(n = 26)的门静脉 BA 浓度比外周高出 9 倍。与此相反,8 人的门静脉 BA 浓度低于外周血,且该区段的非结合型和继发性 BA 含量较高,表明其来源更远。门静脉 BA 特征的改变与肠道微生物群组成的改变有关。特别是,在这些个体的粪便中,乳杆菌(Bacteroides)类群的丰度降低:结论:门静脉乙酰胆碱组成与外周和粪便乙酰胆碱组成的关系特征,增加了对肥胖症患者乙酰胆碱代谢动态的了解。由于微生物的新陈代谢,外周 BA 的组成更加多样化。大约 24% 的门静脉样本中 BA 总含量出奇的低;其潜在机制需要进一步探索。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hepatology
Hepatology 医学-胃肠肝病学
CiteScore
27.50
自引率
3.70%
发文量
609
审稿时长
1 months
期刊介绍: HEPATOLOGY is recognized as the leading publication in the field of liver disease. It features original, peer-reviewed articles covering various aspects of liver structure, function, and disease. The journal's distinguished Editorial Board carefully selects the best articles each month, focusing on topics including immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases, liver cancer, and drug metabolism.
期刊最新文献
Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma. Controversies regarding albumin therapy in cirrhosis. A genetic basis of mitochondrial DNAJA3 in nonalcoholic steatohepatitis-related hepatocellular carcinoma. FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1. Alternatives to animal testing to assess MASH drugs and hepatotoxicity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1